daratumumab interference in pre-transfusion testing
Published 3 years ago • 1.9K plays • Length 10:11Download video MP4
Download video MP3
Similar videos
-
41:47
bmsedg 36: daratumumab: implications in pre-transfusion testing
-
4:02
daratumumab's impact on blood transfusions
-
3:24
does using daratumumab make response-monitoring difficult?
-
32:45
dr. bernard natukunda - pre-transfusion testing and alloimmunization
-
48:26
daratumumab, carfilzomib, lenalidomide & dexamethasone w/ mrd res. adapted therapy in newly diag. mm
-
40:47
evaluation of sustained mrd negativity w/ daratumumab-combination regimens in relapsed refractory mm
-
6:10
updated phase1b results for talquetamab in combination with daratumumab
-
1:47
practical management of iv daratumumab in mm
-
6:03
daratumumab with carfilzomib in frontline multiple myeloma
-
1:09
daratumumab enhancement for mm: the clinical impact
-
2:30
daratumumab and isatuximab in the treatment of multiple myeloma
-
2:24
daratumumab plus vrd for multiple myeloma | nejm
-
3:57
daratumumab in the treatment of mm with high-risk cytogenetics
-
4:22
optimizing treatment sequencing in multiple myeloma: daratumumab upfront versus subsequent lines
-
3:52
analysis of different clinical scenarios using daratumumab | rafael fonseca, md | ash 2021
-
6:59
teclistamab in combination with sub-q daratumumab and lenalidomide in myeloma pts: majestec-2
-
3:36
daratumumab practical considerations in mm
-
9:07
elranatamab in combination with daratumumab for pts with rrmm: phase 3 magnetismm-5